And so, another working week will soon come to an end, but earlier than usual, thanks to a holiday on this side of the pond. This means there is an extended break and we will not return until Monday. For those of you who similarly have an opportunity to enjoy such a respite, we hope you have a relaxing time and dodge those challenging moments when certain family members arrive. Remember, you can always reach for the turkey. As for us, we look forward to assembling our full collection of short people in one spot and enjoying a tradition or two. Meanwhile, we wish you safe travels, merry times and see you soon …

Federal prosecutors have opened a criminal investigation into whether drug makers intentionally allowed opioids to flood communities, employing laws normally used to go after drug dealers, according to The Wall Street Journal. The investigation could become the largest prosecution yet of drug companies alleged to have contributed to the opioid crisis. Prosecutors are examining whether the companies violated the federal Controlled Substances Act, a statute that prosecutors have begun using against opioid makers and distributors this year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy